Disabling viral molecular 'scissor' could lead to COVID-19 drugs (IMAGE)
Caption
The SARS-CoV-2-PLpro enzyme is visualized with an inset of viral inhibitor interaction. Blocking the enzyme's effects may prove fruitful in stopping coronavirus infections.
Credit
Image courtesy Shaun K. Olsen, PhD, laboratory at The University of Texas Health Science Center at San Antonio (Joe R. and Teresa Lozano Long School of Medicine)
Usage Restrictions
None
License
Licensed content